{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:07:50Z","timestamp":1784250470951,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T00:00:00Z","timestamp":1610582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00921"],"award-info":[{"award-number":["PI18\/00921"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 La Marat\u00f3 de TV3","doi-asserted-by":"crossref","award":["60\/U\/2016"],"award-info":[{"award-number":["60\/U\/2016"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2016FI_B 00352"],"award-info":[{"award-number":["2016FI_B 00352"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007512","name":"Universitat Rovira i Virgili","doi-asserted-by":"publisher","award":["URVPFRB21545"],"award-info":[{"award-number":["URVPFRB21545"]}],"id":[{"id":"10.13039\/501100007512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with morbid obesity frequently present non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) associated with pro-atherogenic alterations. Laparoscopic sleeve gastrectomy (LSG) is an effective treatment for weight reduction, and for the remission of hepatic alterations. Using <jats:sup>1<\/jats:sup>H-nuclear magnetic resonance (<jats:sup>1<\/jats:sup>H-NMR), we investigated the effects of LSG on lipoprotein and glycoprotein profile in patients with morbid obesity and liver disease. We included 154 patients with morbid obesity (49 non-NASH, 54 uncertain NASH, 51 definite NASH). A blood sample was obtained before surgery and, in patients with definite NASH, one year after surgery. Patients with NASH had increased concentrations of medium and small VLDL particles, VLDL and IDL cholesterol concentrations, IDL, LDL, and HDL triglyceride concentrations, and elevated glycoprotein levels. These changes were more marked in patients with type 2 diabetes mellitus. LSG produced significant decreases in the concentration of VLDL particles, VLDL cholesterol and triglycerides, an increase in the concentration LDL particles and LDL cholesterol concentrations, and a decrease in protein glycation. We conclude that patients with obesity and NASH had significant alterations in circulating levels of lipoproteins and glycoproteins that were associated with the severity of the disease. Most of these changes were reversed post-LSG.<\/jats:p>","DOI":"10.1038\/s41598-020-79485-7","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T11:11:08Z","timestamp":1610622668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Laparoscopic sleeve gastrectomy alters 1H-NMR-measured lipoprotein and glycoprotein profile in patients with severe obesity and nonalcoholic fatty liver disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Noem\u00ed","family":"Cabr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00edriam","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Amig\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedra","family":"Luciano-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Baiges-Gaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Fern\u00e1ndez-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Rodr\u00edguez-Tom\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hern\u00e1ndez-Aguilera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Par\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e0tima","family":"Sabench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"79485_CR1","unstructured":"Ogden, C.L., Carroll, M.D., Kit, B.K. & Flegal, K.M. Prevalence of obesity among adults: United States, 2011\u20132012. NCHS Data Brief. 1\u20138 (2013)."},{"key":"79485_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1080\/10408398.2011.621772","volume":"54","author":"J Joven","year":"2013","unstructured":"Joven, J., Micol, V., Segura-Carretero, A., Alonso-Villaverde, C. & Menendez, J. A. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease?. Crit. Rev. Food Sci. Nutr. 54, 985\u20131001 (2013).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"79485_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.metabol.2019.07.002","volume":"99","author":"N Cabr\u00e9","year":"2019","unstructured":"Cabr\u00e9, N. et al. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. Metabolism. 99, 81\u201389 (2019).","journal-title":"Metabolism."},{"key":"79485_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen, A. & Yki-J\u00e4rvinen, H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28, 27\u201338 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"79485_CR5","doi-asserted-by":"publisher","first-page":"783976","DOI":"10.1155\/2011\/783976","volume":"2011","author":"K Fon Tacer","year":"2011","unstructured":"Fon Tacer, K. & Rozman, D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids. 2011, 783976 (2011).","journal-title":"J. Lipids."},{"key":"79485_CR6","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","volume":"13","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi, M. et al. Nonalcoholic fatty liver disease is a novel predictor cardiovascular disease. World J. Gastroenterol. 13, 1579\u20131584 (2007).","journal-title":"World J. Gastroenterol."},{"key":"79485_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cgh.2014.10.008","volume":"13","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui, M. S. et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin. Gastroenterol. Hepatol. 13, 1000\u20131008 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"79485_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jacl.2017.02.001","volume":"11","author":"AJ Amor","year":"2017","unstructured":"Amor, A. J. et al. Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia. J. Clin. Lipidol. 11, 551\u2013561 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"79485_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnmrs.2012.09.001","volume":"70","author":"R Mallol","year":"2013","unstructured":"Mallol, R., Rodriguez, M. A., Brezmes, J., Masana, L. & Correig, X. Human serum\/plasma lipoprotein analysis by NMR: Application to the study of diabetic dyslipidemia. Prog. Nucl. Magn. Reson. Spectrosc. 70, 1\u201324 (2013).","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"79485_CR10","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/dc16-1569","volume":"40","author":"C Lorenzo","year":"2017","unstructured":"Lorenzo, C. et al. Novel protein glycan-derived markers of systemic inflammation and C-reactive protein in relation to glycemia, insulin resistance, and insulin decretion. Diabetes Care 40, 375\u2013382 (2017).","journal-title":"Diabetes Care"},{"key":"79485_CR11","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1021\/acs.jproteome.9b00528","volume":"18","author":"R Fuertes-Mart\u00edn","year":"2019","unstructured":"Fuertes-Mart\u00edn, R. et al. Glycoprotein A and B height-to-width ratios as obesity-independent novel biomarkers of low-grade chronic inflammation in women with Polycystic Ovary Syndrome (PCOS). J. Proteome Res. 18, 4038\u20134045. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00528 (2019).","journal-title":"J. Proteome Res."},{"key":"79485_CR12","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.soard.2018.05.027","volume":"14","author":"A Surve","year":"2018","unstructured":"Surve, A. et al. Does the future of laparoscopic sleeve gastrectomy lie in the outpatient surgery center? A retrospective study of the safety of 3162 outpatient sleeve gastrectomies. Surg. Obes. Relat. Dis. 14, 1442\u20131447 (2018).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"79485_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11605-014-2678-y","volume":"19","author":"AA Taitano","year":"2015","unstructured":"Taitano, A. A. et al. Bariatric surgery improves histological features of nonalcoholic fatty liver disease and liver fibrosis. J. Gastrointest. Surg. 19, 429\u2013436 (2015).","journal-title":"J. Gastrointest. Surg."},{"key":"79485_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","volume":"149","author":"G Lassailly","year":"2015","unstructured":"Lassailly, G. et al. Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149, 379\u2013388 (2015).","journal-title":"Gastroenterology"},{"key":"79485_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00464-017-5846-9","volume":"32","author":"RB Luo","year":"2018","unstructured":"Luo, R. B. et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg. Endosc. 32, 1675\u20131682 (2018).","journal-title":"Surg. Endosc."},{"key":"79485_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.soard.2018.07.012","volume":"14","author":"W von Sch\u00f6nfels","year":"2018","unstructured":"von Sch\u00f6nfels, W. et al. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score). Surg. Obes. Relat. Dis. 14, 1607\u20131616 (2018).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"79485_CR17","first-page":"31047","volume":"19","author":"S Ayloo","year":"2019","unstructured":"Ayloo, S., Guss, C., Pentakota, S. R., Hanna, J. & Molinari, M. Minimally invasive sleeve gastrectomy as a surgical treatment for nonalcoholic fatty liver disease in liver transplant recipients. Transplant. Proc. 19, 31047\u201331054 (2019).","journal-title":"Transplant. Proc."},{"issue":"11","key":"79485_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/HMER.S188991","volume":"2019","author":"S Ganguli","year":"2019","unstructured":"Ganguli, S., DeLeeuw, P. & Satapathy, S. K. A review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepat. Med. 2019(11), 159\u2013178 (2019).","journal-title":"Hepat. Med."},{"key":"79485_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/apt.15606","volume":"51","author":"N Cabr\u00e9","year":"2020","unstructured":"Cabr\u00e9, N. et al. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 51, 374\u2013387 (2020).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"79485_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.soard.2012.12.010","volume":"9","author":"JI Mechanick","year":"2013","unstructured":"Mechanick, J. I. et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient\u20132013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Surg. Obes. Relat. Dis. 9, 159\u2013191 (2013).","journal-title":"Surg. Obes. Relat. Dis."},{"key":"79485_CR21","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1007\/s11695-017-2700-z","volume":"27","author":"M Vives","year":"2017","unstructured":"Vives, M. et al. Analysis of gastric physiology after laparoscopic sleeve gastrectomy (LSG) with or without antral preservation in relation to metabolic response: A randomised study. Obes. Surg. 27, 2836\u20132844 (2017).","journal-title":"Obes. Surg."},{"key":"79485_CR22","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa, P. et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56, 1751\u20131759 (2012).","journal-title":"Hepatology"},{"key":"79485_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"79485_CR24","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1002\/cpbi.86","volume":"68","author":"J Chong","year":"2019","unstructured":"Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinform. 68, e86 (2019).","journal-title":"Curr. Protoc. Bioinform."},{"key":"79485_CR25","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1194\/jlr.P054387","volume":"55","author":"VT M\u00e4nnist\u00f6","year":"2014","unstructured":"M\u00e4nnist\u00f6, V. T. et al. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J. Lipid Res. 55, 2676\u20132684 (2014).","journal-title":"J. Lipid Res."},{"key":"79485_CR26","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1021\/acs.jproteome.8b00379","volume":"17","author":"J Allen","year":"2018","unstructured":"Allen, J. et al. Ron receptor signaling ameliorates hepatic fibrosis in a diet-induced nonalcoholic steatohepatitis mouse model. J. Proteome Res. 17, 3268\u20133280 (2018).","journal-title":"J. Proteome Res."},{"key":"79485_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jacl.2018.01.002","volume":"12","author":"JD Otvos","year":"2018","unstructured":"Otvos, J. D. et al. Relations of GlycA and lipoprotein particle subspecies with cardiovascular events and mortality: A post hoc analysis of the AIM-HIGH trial. J. Clin. Lipidol. 12, 348\u2013355 (2018).","journal-title":"J. Clin. Lipidol."},{"key":"79485_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ahj.2018.04.003","volume":"202","author":"JB Muhlestein","year":"2018","unstructured":"Muhlestein, J. B. et al. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study. Am. Heart J. 202, 27\u201332 (2018).","journal-title":"Am. Heart J."},{"key":"79485_CR29","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1021\/acs.jproteome.8b00411","volume":"17","author":"R Fuertes-Mart\u00edn","year":"2018","unstructured":"Fuertes-Mart\u00edn, R. et al. Characterization of (1)H NMR plasma glycoproteins as a new strategy to identify inflammatory patterns in rheumatoid arthritis. J. Proteome Res. 17, 3730\u20133739 (2018).","journal-title":"J. Proteome Res."},{"key":"79485_CR30","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/1873-3468.13495","volume":"593","author":"N Rudman","year":"2019","unstructured":"Rudman, N., Gornik, O. & Lauc, G. Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes. FEBS Lett. 593, 1598\u20131615 (2019).","journal-title":"FEBS Lett."},{"key":"79485_CR31","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1002\/1873-3468.13598","volume":"593","author":"V Dotz","year":"2019","unstructured":"Dotz, V. & Wuhrer, M. N-glycome signatures in human plasma: associations with physiology and major diseases. FEBS Lett. 593, 2966\u20132976. https:\/\/doi.org\/10.1002\/1873-3468.13598 (2019).","journal-title":"FEBS Lett."},{"key":"79485_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ijo.2014.53","volume":"39","author":"E Rodr\u00edguez-Gallego","year":"2015","unstructured":"Rodr\u00edguez-Gallego, E. et al. Mapping of the circulating metabolome reveals \u03b1-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. Int. J. Obes. (Lond) 39, 279\u2013287 (2015).","journal-title":"Int. J. Obes. (Lond)"},{"key":"79485_CR33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/apt.15216","volume":"49","author":"KE Corey","year":"2019","unstructured":"Corey, K. E. et al. Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial. Aliment. Pharmacol. Ther. 49, 1205\u20131213 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"79485_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7555\/JBR.27.20120077","volume":"27","author":"ZG Jiang","year":"2013","unstructured":"Jiang, Z. G., Robson, S. C. & Yao, Z. Lipoprotein metabolism in nonalcoholic fatty liver disease. J. Biomed. Res. 27, 1\u201313 (2013).","journal-title":"J. Biomed. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79485-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79485-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:06:34Z","timestamp":1670033194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-79485-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["79485"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-79485-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,14]]},"assertion":[{"value":"17 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. M\u00edriam Gil is an employee and Dr. N\u00faria Amig\u00f3 is a stock owner of Biosfer Teslab S.L. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1343"}}